# A Study to Evaluate the Efficacy of ELAPR002f in Females and Males With Atrophic Acne Scars

> **NCT03056235** · NA · COMPLETED · sponsor: **Elastagen Pty Ltd** · enrollment: 30 (actual)

## Conditions studied

- Atrophic Acne Scar

## Interventions

- **DEVICE:** ELAPR002f
- **DEVICE:** Saline

## Key facts

- **NCT ID:** NCT03056235
- **Lead sponsor:** Elastagen Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2018-03-23
- **Final completion:** 2018-09-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03056235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03056235, "A Study to Evaluate the Efficacy of ELAPR002f in Females and Males With Atrophic Acne Scars". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03056235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*